Affimed N.V. (NASDAQ: AFMD) kicked off on June 22, 2022, at the price of $2.50, up 6.64% from the previous trading day. During the day, the shares moved up to $2.80 and dropped to $2.46 before settling in for the closing price of $2.56. Over the past 52 weeks, AFMD has traded in a range of $2.23-$8.81.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 44.90%. While this was happening, its average annual earnings per share was recorded 2.90%. With a float of $99.39 million, this company’s outstanding shares have now reached $123.44 million.
The extent of productivity of a business whose workforce counts for 187 workers is very important to gauge.
Affimed N.V. (AFMD) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Affimed N.V. is 3.40%, while institutional ownership is 54.40%.
Affimed N.V. (AFMD) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 12/30/2021, the organization reported -$0.2 earnings per share (EPS), lower than consensus estimate (set at -$0.16) by -$0.04. This company achieved a net margin of -142.50 while generating a return on equity of -56.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.21 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 2.90% per share during the next fiscal year.
Affimed N.V. (NASDAQ: AFMD) Trading Performance Indicators
Take a look at Affimed N.V.’s (AFMD) current performance indicators. Last quarter, stock had a quick ratio of 3.10. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.73.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.66, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -0.79 in one year’s time.
Technical Analysis of Affimed N.V. (AFMD)
The latest stats from [Affimed N.V., AFMD] show that its last 5-days average volume of 1.11 million was inferior to 1.53 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 44.80%. Additionally, its Average True Range was 0.23.
During the past 100 days, Affimed N.V.’s (AFMD) raw stochastic average was set at 17.42%, which indicates a significant decrease from 49.50% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 83.98% in the past 14 days, which was higher than the 71.51% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.35, while its 200-day Moving Average is $4.88. Now, the first resistance to watch is $2.87. This is followed by the second major resistance level at $3.00. The third major resistance level sits at $3.21. If the price goes on to break the first support level at $2.53, it is likely to go to the next support level at $2.32. Assuming the price breaks the second support level, the third support level stands at $2.19.
Affimed N.V. (NASDAQ: AFMD) Key Stats
The company with the Market Capitalisation of 376.36 million has total of 123,420K Shares Outstanding. Its annual sales at the moment are 47,760 K in contrast with the sum of -68,060 K annual income. Company’s last quarter sales were recorded 8,980 K and last quarter income was -18,700 K.
